Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JinLong Xu

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 15, 2026
A Novel GmSIN1-GmRNF1a-GmCSN5a Module Determines Soybean Salt Tolerance and Yield Under Saline Soil ConditionsJinlong Xu, Mengqi Shan, Xinxin Yang, et al.
Nature Communications|November 9, 2021
High-harmonic generation in Weyl semimetal β-WP<sub>2</sub> crystalsYang-Yang Lv, Jinlong Xu, Shuang Han, et al.
Journal of Hematology & Oncology|April 5, 2023
Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemiaYue Tan, Lingling Shan, Liping Zhao, et al.
Nature Medicine|October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trialJing Pan, Yue Tan, Lingling Shan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I TrialJing Pan, Yue Tan, Guoling Wang, et al.
The Lancet. Oncology|October 20, 2023
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 studyJing Pan, Kaiting Tang, Yuechen Luo, et al.
ACS Applied Materials & Interfaces|February 19, 2026
Phase-Selective Growth of Ferroelectric and Antiferroelectric NaNbO<sub>3</sub> Thin FilmsBaichen Lin, Qibin Zeng, Ping Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2024
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trialLiping Zhao, Chuo Li, Shiyu Zuo, et al.
Nature Communications|July 22, 2024
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trialShiyu Zuo, Chuo Li, Xiaolei Sun, et al.
JBI Evidence Implementation|June 22, 2026
Prevention of aggression in psychiatric patients in five psychiatric hospitals in China: a best practice implementation projectYing Ma, Jieying Xie, Dan Xu, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 15, 2026
A Novel GmSIN1-GmRNF1a-GmCSN5a Module Determines Soybean Salt Tolerance and Yield Under Saline Soil ConditionsJinlong Xu, Mengqi Shan, Xinxin Yang, et al.
Nature Communications|November 9, 2021
High-harmonic generation in Weyl semimetal β-WP<sub>2</sub> crystalsYang-Yang Lv, Jinlong Xu, Shuang Han, et al.
Journal of Hematology & Oncology|April 5, 2023
Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemiaYue Tan, Lingling Shan, Liping Zhao, et al.
Nature Medicine|October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trialJing Pan, Yue Tan, Lingling Shan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I TrialJing Pan, Yue Tan, Guoling Wang, et al.
The Lancet. Oncology|October 20, 2023
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 studyJing Pan, Kaiting Tang, Yuechen Luo, et al.
ACS Applied Materials & Interfaces|February 19, 2026
Phase-Selective Growth of Ferroelectric and Antiferroelectric NaNbO<sub>3</sub> Thin FilmsBaichen Lin, Qibin Zeng, Ping Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2024
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trialLiping Zhao, Chuo Li, Shiyu Zuo, et al.
Nature Communications|July 22, 2024
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trialShiyu Zuo, Chuo Li, Xiaolei Sun, et al.
JBI Evidence Implementation|June 22, 2026
Prevention of aggression in psychiatric patients in five psychiatric hospitals in China: a best practice implementation projectYing Ma, Jieying Xie, Dan Xu, et al.
Pageof 10